151 related articles for article (PubMed ID: 33402458)
1. Low DUSP4 Expression Is Associated With Aggressive Phenotypes and Poor Prognosis in Gastric Cancer.
Bang S; Jee S; Kim H; Jang K; Park H; Myung JK; Choi D; Shin SJ; Paik SS
In Vivo; 2021; 35(1):131-140. PubMed ID: 33402458
[TBL] [Abstract][Full Text] [Related]
2. Low expression of DUSP4 expression predicts unfavorable prognosis in gallbladder adenocarcinoma.
Jee S; Sim J; Bang S; Park H; Myung J; Paik SS; Choi D; Kim Y; Kim H
Indian J Pathol Microbiol; 2022; 65(4):809-813. PubMed ID: 36308185
[TBL] [Abstract][Full Text] [Related]
3. MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.
Xu X; Gao F; Wang J; Tao L; Ye J; Ding L; Ji W; Chen X
Cancer Biol Ther; 2018 May; 19(5):427-435. PubMed ID: 29509059
[TBL] [Abstract][Full Text] [Related]
4. Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.
Zhang R; Wang G; Zhang PF; Zhang J; Huang YX; Lu YM; Da W; Sun Q; Zhu JS
J Cell Mol Med; 2017 Jun; 21(6):1117-1127. PubMed ID: 27957827
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of DUSP4 is associated with liver and lung metastases in colorectal cancer.
Saigusa S; Inoue Y; Tanaka K; Toiyama Y; Okugawa Y; Shimura T; Hiro J; Uchida K; Mohri Y; Kusunoki M
Med Oncol; 2013; 30(3):620. PubMed ID: 23749251
[TBL] [Abstract][Full Text] [Related]
6. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH
Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618
[TBL] [Abstract][Full Text] [Related]
7. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
[TBL] [Abstract][Full Text] [Related]
8. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL
Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Dual-Specific Phosphatase 4 mRNA Expression Before and after Neoadjuvant Chemotherapy in Breast Cancer.
Prihantono P; Usman AN; Binekada C; Hatta M; Islam AA
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1051-1055. PubMed ID: 31030473
[TBL] [Abstract][Full Text] [Related]
10. Lysine-Specific Histone Demethylase 1 Promotes Oncogenesis of the Esophageal Squamous Cell Carcinoma by Upregulating DUSP4.
Han J; Ye S; Chen J; Wang K; Jin J; Zeng Z; Xue S
Biochemistry (Mosc); 2021 Dec; 86(12):1624-1634. PubMed ID: 34937541
[TBL] [Abstract][Full Text] [Related]
11. Expression of
Varela T; Laizé V; Conceição N; Caldeira P; Marreiros A; Guerreiro H; Cancela ML
Biomark Med; 2020 Jun; 14(8):639-650. PubMed ID: 32613839
[No Abstract] [Full Text] [Related]
12. Loss of DUSP4 Expression as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.
Bang S; Jee S; Son H; Wi YC; Kim H; Park H; Myung J; Shin SJ; Paik SS
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679636
[TBL] [Abstract][Full Text] [Related]
13. Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.
Jung HH; Lee SH; Kim JY; Ahn JS; Park YH; Im YH
Sci Rep; 2016 Sep; 6():33035. PubMed ID: 27604655
[TBL] [Abstract][Full Text] [Related]
14. miR‑122‑5p suppresses the oncogenesis of PTC by inhibiting DUSP4 expression.
Hu N; Tian Y; Song Y; Zang L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760201
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of dual-specificity protein phosphatase 4 expression in invasive ductal carcinoma of the breast.
Kim H; Jang SM; Ahn H; Sim J; Yi K; Chung Y; Han H; Rehman A; Chung MS; Jang K; Paik SS
J Breast Cancer; 2015 Mar; 18(1):1-7. PubMed ID: 25834604
[TBL] [Abstract][Full Text] [Related]
16. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
Balko JM; Cook RS; Vaught DB; Kuba MG; Miller TW; Bhola NE; Sanders ME; Granja-Ingram NM; Smith JJ; Meszoely IM; Salter J; Dowsett M; Stemke-Hale K; González-Angulo AM; Mills GB; Pinto JA; Gómez HL; Arteaga CL
Nat Med; 2012 Jul; 18(7):1052-9. PubMed ID: 22683778
[TBL] [Abstract][Full Text] [Related]
17. Investigating the Role of DUSP4 in Uveal Melanoma.
Aughton K; Sabat-Pospiech D; Barlow S; Coupland SE; Kalirai H
Transl Vis Sci Technol; 2022 Dec; 11(12):13. PubMed ID: 36576731
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.
Ichimanda M; Hijiya N; Tsukamoto Y; Uchida T; Nakada C; Akagi T; Etoh T; Iha H; Inomata M; Takekawa M; Moriyama M
Cancer Sci; 2018 Jan; 109(1):250-258. PubMed ID: 29150975
[TBL] [Abstract][Full Text] [Related]
19. Proteomic Signaling of Dual-Specificity Phosphatase 4 (DUSP4) in Alzheimer's Disease.
Wang E; Pan AL; Bagchi P; Rangaraju S; Seyfried NT; Ehrlich ME; Salton SR; Zhang B
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254666
[TBL] [Abstract][Full Text] [Related]
20. The microRNA-429/DUSP4 axis regulates the sensitivity of colorectal cancer cells to nintedanib.
Cheng G; Li Y; Liu Z; Song X
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33495832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
